{"article_title": "Under Obamacare, Will America Keep Winning The War On Cancer?", "article_keywords": ["america", "obamacare", "war", "cancer", "winning"], "article_url": "http://www.forbes.com/sites/theapothecary/2015/01/23/under-obamacare-will-america-keep-winning-the-war-on-cancer/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "The Apothecary", "og": {"site_name": "Forbes", "description": "Annual statistics reporting from the American Cancer Society shows the death rate from cancer in the US has fallen 22% from its peak in 1991. This translates to more than 1.5 million deaths from cancer that were avoided. Unfortuntately, most of Obamacare's newly insured will be dependent on Medicaid, where breast-cancer patients have worse health outcomes than privately insured patients. As for those on Obamacare's health insurance exchanges, Avalere, a healthcare consulting practice, has published a series of papers analyzing prescription coverage in those plans. The latest concludes that they have complicated, multiple tiers of co-pays and co-insurance for specialty drugs, including cancer drugs.", "title": "Under Obamacare, Will America Keep Winning The War On Cancer?", "url": "http://www.forbes.com/sites/theapothecary/2015/01/23/under-obamacare-will-america-keep-winning-the-war-on-cancer/", "image": "http://blogs-images.forbes.com/theapothecary/files/2015/01/g1.jpg", "updated_time": "2015-01-23T14:26:50-05:00", "type": "article"}, "twitter": {"description": "Annual statistics reporting from the American Cancer Society shows the death rate from cancer in the US has fallen 22% from its peak in 1991. This translates to more than 1.5 million deaths from cancer that were avoided. Unfortuntately, most of Obamacare's newly insured will be dependent on Medicaid, where breast-cancer patients have worse health outcomes than privately insured patients. As for those on Obamacare's health insurance exchanges, Avalere, a healthcare consulting practice, has published a series of papers analyzing prescription coverage in those plans. The latest concludes that they have complicated, multiple tiers of co-pays and co-insurance for specialty drugs, including cancer drugs.", "creator": "@forbesopinion", "image": "http://blogs-images.forbes.com/theapothecary/files/2015/01/g1.jpg", "title": "Under Obamacare, Will America Keep Winning The War On Cancer?", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Healthcare  Fiscal,OpEd,Healthcare &amp; Fiscal,Op/Ed", "article": {"publisher": "https://www.facebook.com/forbes", "author": "http://www.facebook.com/https://www.facebook.com/forbesaroy", "section_url": "http://www.forbes.com/opinion", "section": "Opinion", "modified": "2015-01-23", "published": "2015-01-23", "id": "blogAndPostId/blog/post/1314-23229"}, "news_keywords": "Healthcare  Fiscal,OpEd,Healthcare &amp; Fiscal,Op/Ed", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "Annual statistics reporting from the American Cancer Society shows the death rate from cancer in the US has fallen 22% from its peak in 1991. This translates to more than 1.5 million deaths from cancer that were avoided. Unfortuntately, most of Obamacare's newly insured will be dependent on Medicaid, where breast-cancer patients have worse health outcomes than privately insured patients. As for those on Obamacare's health insurance exchanges, Avalere, a healthcare consulting practice, has published a series of papers analyzing prescription coverage in those plans. The latest concludes that they have complicated, multiple tiers of co-pays and co-insurance for specialty drugs, including cancer drugs."}, "_id": "\"57477af36914bd0286fce742\"", "article_summary": ""}